{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T09:59:41Z","timestamp":1768730381560,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Thailand Science Research and Innovation Fundamental Fund fiscal year 2023","award":["TUFF75\/2566"],"award-info":[{"award-number":["TUFF75\/2566"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05305-w","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:47:04Z","timestamp":1740746824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic polymorphisms of Plasmodium vivax transmission-blocking vaccine candidates Pvs48\/45 and Pvs47 in Thailand"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiraporn","family":"Kuesap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nutnicha","family":"Suphakhonchuwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benyapa","family":"Eksonthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saranchana","family":"Huaihongthong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"5305_CR1","unstructured":"WHO. World Malaria Report 2023. Geneva: World Health Organization; 2023. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023. 2023. Accessed 8 June 2024."},{"key":"5305_CR2","unstructured":"DDC. Thailand malaria elimination programme. Department of disease control (DDC), Ministry of public health, Thailand. 2023. https:\/\/malaria.ddc.moph.go.th\/malariaR10\/home.php. Accessed 8 June 2024."},{"key":"5305_CR3","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/S0264-410X(00)00521-1","volume":"19","author":"R Carter","year":"2021","unstructured":"Carter R. Transmission blocking malaria vaccines. Vaccine. 2021;19:2309\u201314.","journal-title":"Vaccine"},{"key":"5305_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1383-5769(02)00037-5","volume":"52","author":"T Tsuboi","year":"2003","unstructured":"Tsuboi T, Tachibana M, Kaneko O, Torii M. Transmission blocking vaccine of vivax malaria. Parasitol Int. 2003;52:1\u201311.","journal-title":"Parasitol Int"},{"key":"5305_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.apar.2015.04.001","volume":"89","author":"Y Wu","year":"2015","unstructured":"Wu Y, Sinden RE, Churcher TS, Tsuboi T, Yusibov V. Development of malaria transmission-blocking vaccines: from concept to product. Adv Parasitol. 2015;89:109\u201352.","journal-title":"Adv Parasitol"},{"key":"5305_CR6","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.vaccine.2015.03.008","volume":"33","author":"M Tachibana","year":"2015","unstructured":"Tachibana M, Suwanabun N, Kaneko O, Iriko H, Otsuki H, Sattabongkot J, et al. Plasmodium vivax gametocyte proteins, Pvs48\/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization. Vaccine. 2015;33:1901\u20138.","journal-title":"Vaccine"},{"key":"5305_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00374-23","volume":"92","author":"GP Bansal","year":"2024","unstructured":"Bansal GP, Araujo MdS, Cao Y, Shaffer E, Araujo JE, Medeiros JF, et al. Transmission-reducing and -enhancing monoclonal antibodies against Plasmodium vivax gamete surface protein Pvs48\/45. Infect Immun. 2024;92: e0037423.","journal-title":"Infect Immun."},{"key":"5305_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4269\/ajtmh.2005.73.5_suppl.0730038","volume":"73","author":"M Arevalo-Herrera","year":"2005","unstructured":"Arevalo-Herrera M, Solarte Y, Zamora F, Mendez F, Yasnot MF, Rocha L, et al. Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia. Am J Trop Med Hyg. 2005;73:38\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"5305_CR9","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1128\/IAI.68.12.6618-6623.2000","volume":"68","author":"H Hisaeda","year":"2000","unstructured":"Hisaeda H, Stowers AW, Tsuboi T, Collins WE, Sattabongkot JS, Suwanabun N, et al. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infect Immun. 2000;68:6618\u201323.","journal-title":"Infect Immun"},{"key":"5305_CR10","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1126\/science.1925544","volume":"252","author":"DC Kaslow","year":"1991","unstructured":"Kaslow DC, Isaacs SN, Quakyi IA, Gwadz RW, Moss B, Keister DB. Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science. 1991;252:1310\u20133.","journal-title":"Science"},{"key":"5305_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/BF03401770","volume":"4","author":"T Tsuboi","year":"1998","unstructured":"Tsuboi T, Kaslow DC, Gozar MM, Tachibana M, Cao YM, Torii M. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Mol Med. 1998;4:772\u201382.","journal-title":"Mol Med"},{"key":"5305_CR12","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1096\/fj.13-241570","volume":"28","author":"T Annoura","year":"2014","unstructured":"Annoura T, van Schaijk BC, Ploemen IH, Sajid M, Lin JW, Vos MW, et al. Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development. FASEB J. 2014;28:2158\u201370.","journal-title":"FASEB J"},{"key":"5305_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000853","volume":"6","author":"MR van Dijk","year":"2010","unstructured":"van Dijk MR, van Schaijk BC, Khan SM, van Dooren MW, Ramesar J, Kaczanowski S, et al. Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility. PLoS Pathog. 2010;6: e1000853.","journal-title":"PLoS Pathog"},{"key":"5305_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s13071-015-1232-4","volume":"8","author":"H Feng","year":"2015","unstructured":"Feng H, Gupta B, Wang M, Zheng W, Zheng L, Zhu X, et al. Genetic diversity of transmission-blocking vaccine candidate Pvs48\/45 in Plasmodium vivax populations in China. Parasit Vectors. 2015;8:615.","journal-title":"Parasit Vectors"},{"key":"5305_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12936-016-1263-0","volume":"15","author":"AF Vallejo","year":"2016","unstructured":"Vallejo AF, Martinez NL, Tobon A, Alger J, Lacerda MV, Kajava AV, et al. Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48\/45. Malar J. 2016;15:202.","journal-title":"Malar J"},{"key":"5305_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1475-2875-12-144","volume":"12","author":"JM Kang","year":"2013","unstructured":"Kang JM, Ju HL, Moon SU, Cho PY, Bahk YY, Sohn WM, et al. Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates. Malar J. 2013;12:144.","journal-title":"Malar J"},{"key":"5305_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104710","volume":"89","author":"S Asali","year":"2021","unstructured":"Asali S, Raz A, Turki H, Mafakher L, Razmjou E, Solaymani-Mohammadi S. Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48\/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development. Infect Genet Evol. 2021;89: 104710.","journal-title":"Infect Genet Evol"},{"key":"5305_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1590\/S0074-02762013000300015","volume":"108","author":"MK Woo","year":"2013","unstructured":"Woo MK, Kim KA, Kim J, Oh JS, Han ET, An SS, et al. Sequence polymorphisms in Pvs48\/45 and Pvs47 gametocyte and gamete surface proteins in Plasmodium vivax isolated in Korea. Mem Inst Oswaldo Cruz. 2013;108:359\u201367.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5305_CR19","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/genetics\/143.3.1457","volume":"143","author":"F Tajima","year":"1996","unstructured":"Tajima F. The amount of DNA polymorphism maintained in a finite population when the neutral mutation rate varies among sites. Genetics. 1996;143:1457\u201365.","journal-title":"Genetics"},{"key":"5305_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/BF00167113","volume":"40","author":"Y Ina","year":"1995","unstructured":"Ina Y. New methods for estimating the numbers of synonymous and nonsynonymous substitutions. J Mol Evol. 1995;40:190\u2013226.","journal-title":"J Mol Evol"},{"key":"5305_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/oxfordjournals.molbev.a026036","volume":"16","author":"HJ Bandelt","year":"1999","unstructured":"Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecifc phylogenies. Mol Biol Evol. 1999;16:37\u201348.","journal-title":"Mol Biol Evol"},{"key":"5305_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004786","volume":"10","author":"RA Chaurio","year":"2016","unstructured":"Chaurio RA, Pacheco MA, Cornejo OE, Durrego E, Stanley CE Jr, Castillo AI, Herrera S, Escalante AA. Evolution of the transmission-blocking vaccine candidates Pvs28 and Pvs25 in Plasmodium vivax: geographic differentiation and evidence of positive selection. PLoS Negl Trop Dis. 2016;10: e0004786.","journal-title":"PLoS Negl Trop Dis"},{"key":"5305_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/1755-0998.12654","volume":"17","author":"AG Nazareno","year":"2017","unstructured":"Nazareno AG, Bemmels JB, Dick CW, Lohmann LG. Minimum sample sizes for population genomics: an empirical study from an Amazonian plant species. Mol Ecol Resour. 2017;17:1136\u201347.","journal-title":"Mol Ecol Resour"},{"key":"5305_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042649","volume":"7","author":"EM Willing","year":"2012","unstructured":"Willing EM, Dreyer C, van Oosterhout C. Estimates of genetic differentiation measured by F(ST) do not necessarily require large sample sizes when using many SNP markers. PLoS ONE. 2012;7: e42649.","journal-title":"PLoS ONE"},{"key":"5305_CR25","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1016\/j.vaccine.2011.04.028","volume":"29","author":"M Doi","year":"2011","unstructured":"Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, et al. Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax. Vaccine. 2011;29:4308\u201315.","journal-title":"Vaccine"},{"key":"5305_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.actatropica.2008.09.012","volume":"109","author":"S Zakeri","year":"2009","unstructured":"Zakeri S, Razavi S, Djadid ND. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran. Acta Trop. 2009;109:176\u201380.","journal-title":"Acta Trop"},{"key":"5305_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2024.105558","volume":"118","author":"J Kuesap","year":"2024","unstructured":"Kuesap J, Suphakhonchuwong N, Rungsihirunrat K. Genetic polymorphisms of Plasmodium vivax ookinete (sexual stage) surface proteins (Pvs25 and Pvs28) from Thailand. Infect Genet Evol. 2024;118: 105558.","journal-title":"Infect Genet Evol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05305-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05305-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05305-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:47:09Z","timestamp":1740746829000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05305-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5305"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05305-w","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Ethics Committee of Thammasat University (COA No. 042\/2564).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}